Ralph J Gitomer

Array ( [id] => 14115655 [patent_doc_number] => RE047333 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-04-02 [patent_title] => Pharmaceutical formulations containing dopamine receptor ligands [patent_app_type] => reissue [patent_app_number] => 15/598784 [patent_app_country] => US [patent_app_date] => 2017-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12101 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14167955 [patent_doc_number] => RE047350 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-04-16 [patent_title] => Pharmaceutical formulations containing dopamine receptor ligands [patent_app_type] => reissue [patent_app_number] => 15/598971 [patent_app_country] => US [patent_app_date] => 2017-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12119 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13247789 [patent_doc_number] => RE047141 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-11-27 [patent_title] => Methods of treating fibrosis, cancer and vascular injuries [patent_app_type] => reissue [patent_app_number] => 15/382065 [patent_app_country] => US [patent_app_date] => 2016-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 33 [patent_no_of_words] => 24064 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 228 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13219413 [patent_doc_number] => RE047122 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-11-13 [patent_title] => 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors [patent_app_type] => reissue [patent_app_number] => 15/382135 [patent_app_country] => US [patent_app_date] => 2016-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26268 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11857304 [patent_doc_number] => RE046518 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-08-22 [patent_title] => 'Compositions relating to a mutant Clostridium difficile toxin and methods thereof' [patent_app_type] => reissue [patent_app_number] => 15/366702 [patent_app_country] => US [patent_app_date] => 2016-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 56 [patent_no_of_words] => 64865 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13115455 [patent_doc_number] => RE047045 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-09-18 [patent_title] => Compositions and methods for treating macular degeneration [patent_app_type] => reissue [patent_app_number] => 15/343016 [patent_app_country] => US [patent_app_date] => 2016-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10617 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11457128 [patent_doc_number] => 20170051033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-23 [patent_title] => 'Variants of C-Type Natriuretic Peptide' [patent_app_type] => utility [patent_app_number] => 15/332793 [patent_app_country] => US [patent_app_date] => 2016-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 74178 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15332793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14848327 [patent_doc_number] => RE047607 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-09-17 [patent_title] => Luciferase signal enhancing compositions [patent_app_type] => reissue [patent_app_number] => 15/292259 [patent_app_country] => US [patent_app_date] => 2016-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 46 [patent_no_of_words] => 16812 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15292259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13206035 [patent_doc_number] => RE047115 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-11-06 [patent_title] => Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis [patent_app_type] => reissue [patent_app_number] => 15/230189 [patent_app_country] => US [patent_app_date] => 2016-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9402 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15230189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14084269 [patent_doc_number] => RE047316 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-03-26 [patent_title] => Oral formulations of ospemifene [patent_app_type] => reissue [patent_app_number] => 15/191316 [patent_app_country] => US [patent_app_date] => 2016-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2033 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15191316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13075913 [patent_doc_number] => RE047009 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-08-28 [patent_title] => HDAC inhibitors and therapeutic methods using the same [patent_app_type] => reissue [patent_app_number] => 15/182061 [patent_app_country] => US [patent_app_date] => 2016-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 30216 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15182061 [rel_patent_id] =>[rel_patent_doc_number] =>)